Response to Pyrotinib in a Patient with Metastatic Bladder Urothelial Carcinoma Harboring HER2 V842I Mutation: A Case Report.

Li, Suyao; Liu, Qing; Liu, Mengling; Liu, Tianshu.

Afiliação

Li S; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
Liu Q; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
Liu M; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
Liu T; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.

Cancer Manag Res ; 14: 2927-2932, 2022.

Article em En | MEDLINE | ID: mdl-36200096